Company | Science | Strategy | People | News

News

Quantum Genomics gets approval from the Patients’ Protection Committee.  
QGC 05-01-2012 Read More
Quantum Genomics a reçu l’avis favorable du Comité de Protection des Personnes.  
QGC 05-01-2012 Read More
QUANTUM GENOMICS (NYSE EURONEXT PARIS: MLQGC) ANNOUNCED TODAY POSITIVE SCIENTIFIC RESULTS WITH ITS PRODUCT QGC001  
QGC 01-04-2011 Read More
Quantum Genomics (NYSE Euronext Paris: MLQGC) announced today that EUR 1.4 million in funding has been granted by the National Research Agency (ANR) for a collaborative research project named BAPAI  
QGC 01-02-2011 Read More
Quantum Genomics enters the NYSE-Euronext Market (MLQGC)  
QGC 28-07-2009 Read More
Quantum Genomics gets 1 Million $ (740 K€) from Oseo to finance the regulatory preclinical development of QGC 001.  
QGC 02-04-2009 Read More
Quantum Genomics Corp signs strategic agreement with PCAS to make first batch of hypertension drug candidate  
QGC 08-07-2008 Read More
Quantum Genomics Corp partners with Inserm in stroke and cardiac ischemia drug development  
QGC 24-01-2008 Read More
Quantum Genomics widens net with acquisition of Eurobiobiz SAS  
QGC 29-10-2007 Read More
Quantum Genomics Corp partners with Inserm and CNRS in hypertension drug development  
QGC 28-06-2007 Read More
Quantum Genomics Corp. appoints Fabrice Balavoine Head of Research  
QGC 18-12-2006 Read More
QGC names Jean-Pierre Riffaud Head of Preclinical Development  
QGC 18-10-2006 Read More
Quantum Genomics Corp opens European HQ in Paris region  
QGC 03-07-2006 Read More
QGC names Lionel SEGARD CEO  
QGC 06-06-2006 Read More
 
Company | Science | Strategy | People | News